Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Retroviral insertional mutagenesis has been proposed as an efficient mechanism to turn on or to increase the expression of oncogenes in several avian or mammal models. Integration site studies of avian leukosis virus, murine leukaemia and murine mammary tumour viruses led to the coleutification of highly conserved genes whose expression is induced or increased during leukaemogenesis, probably through enhancer elements present in the retroviral long terminal repeats. This is reminiscent of the activation of cellular proto-oncogenes or putative oncogenes in numerous human tumours and leukaemias as a result of chromosomal translocations or DNA rearrangements. Here we report the characterization of a new putative oncogene isolated from a murine erythroleukaemia induced by the acute leukaemogenic retrovirus spleen focus forming virus (SFFV). An important and unusual feature of this genomic locus Spi-1 (for SFFV proviral integration) is that rearrangements due to SFFV integration were found in 95% of the erythroid tumours studied. A 4.0-kilobase messenger RNA was detected in rearranged tumours. No Spi-1 rearrangement was detected in other virally induced myeloid, lymphoid or erythroid tumours tested.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aberrant expression of PU.1 inhibits erythroid cell differentiation and contributes to the formation of murine erythroleukemias (MEL).”
From Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1 (2002) · cites this paper as [50]
In the citing paper
“However, CellOracle did not detect a previously reported depletion of erythrocyte progenitors after Spi1 KO27,28, probably owing to changes in cell proliferation that are not predicted by the method.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [28]
In the citing paper
“PU.1 (Spi-1), a member of this family, is encoded by proto-oncogene sfpi-1 and is expressed exclusively in haematopoietic cells, with high levels detected in monocytic, granulocytic and B lymphoid lineages [16–20].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [16]
In the citing paper
“PU.1 is an Ets-family transcription factor which controls many critical genes important for the development of white cells within the hematopoietic system, in particular, myeloid and B cells”
From Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element (2005) · cites this paper as [34]
In the citing paper
“The SFFV provirus integration sites span several kilobases approximately 14 kb 5Ј of the PU.1 coding region (34,44).”
From Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element (2005) · cites this paper as [34]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Nusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Theo Cuypers, H., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., & Berns, A. (1984) · Cell · doi:10.1016/0092-8674(84)90309-x · Cited by 639
Novel bacteriophage lambda cloning vector.
Karn, J., Brenner, S., Barnett, L., & Cesareni, G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5172 · Cited by 386
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
Mowat, M., Cheng, A., Kimura, N., Bernstein, A., & Benchimol, S. (1985) · Nature · doi:10.1038/314633a0 · Cited by 320
Peters, G., Brookes, S., Smith, R., & Dickson, C. (1983) · Cell · doi:10.1016/0092-8674(83)90418-x · Cited by 320
Fung, Y.-K. T., Lewis, W. G., Crittenden, L. B., & Kung, H.-J. (1983) · Cell · doi:10.1016/0092-8674(83)90417-8 · Cited by 281
Activation of the c- myb Locus by Viral Insertional Mutagenesis in Plasmacytoid Lymphosarcomas
Shen-Ong, G. L. C., Potter, M., Mushinski, J. F., Lavu, S., & Reddy, E. P. (1984) · Science · doi:10.1126/science.6093260 · Cited by 143
Specific integration of REV proviruses in avian bursal lymphomas
Noori-Daloii, M.-R., Swift, R. A., Kung, H.-J., Crittenden, L. B., & Witter, R. L. (1981) · Nature · doi:10.1038/294574a0 · Cited by 130
Linemeyer, D. L., Menke, J. G., Ruscetti, S. K., Evans, L. H., & Scolnick, E. M. (1982) · Journal of Virology · doi:10.1128/jvi.43.1.223-233.1982 · Cited by 110
Cited by
Items 201–300 of 454
Zochodne, B., Truong, A. H. L., Stetler, K., Higgins, R. R., Howard, J., Dumont, D. J., Berger, S. A., & Ben‐David, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203590 · Cited by 43
Yamada, T., Kihara-Negishi, F., Yamamoto, H., Yamamoto, M., Hashimoto, Y., & Oikawa, T. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4251 · Cited by 35
Rimmelé, P., Kosmider, O., Mayeux, P., Moreau-Gachelin, F., & Guillouf, C. (2007) · Blood · doi:10.1182/blood-2006-03-006718 · Cited by 35
Self-citationDekoninck, A., Calomme, C., Nizet, S., de Launoit, Y., Burny, A., Ghysdael, J., & Lint, C. M. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206392 · Cited by 38
“A PU.1/Spi-1 binding site has been identified by our laboratory in a transcriptional regulatory element, which is located in the pol gene of HIV-1 and is associated with a nucleasehypersensitive site.”
BackgroundInfluentialGenua, C. D., Valletta, S., Buono, M., Stoilova, B., Sweeney, C., Rodríguez-Meira, A., Grover, A., Drissen, R., Meng, Y., Beveridge, R. D. D., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.022 · Cited by 37
Zarnegar, M. A., & Rothenberg, E. V. (2012) · Oncogene · doi:10.1038/onc.2011.597 · Cited by 37
“1, upregulated in virally-induced erythroleukemias, is an Ets family transcription factor encoded by the Sfpi1/Spi-1 gene (1).”
Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation
Moreau-Gachelin, F. (2008) · Retrovirology · doi:10.1186/1742-4690-5-99 · Cited by 42
“The molecular characterization of the SFFV integration sites revealed that SFFVP or SFFVA preferentially integrates at the same genomic locus in 95% of the Friend tumor cells, called spi-1 for SFFV proviral integration site-1 [64,65].”
BackgroundSelf-citationBuras, J. A., Reenstra, W. R., & Fenton, M. J. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00018-a · Cited by 23
Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice
Bašová, P., Pospíšil, V., Savvulidi, F. G., Burda, P., Vargová, K., Staněk, L., Dluhošová, M., Kužmová, E., Jonasova, A. T., Steidl, U. G., et al. (2013) · Oncogene · doi:10.1038/onc.2013.414 · Cited by 37
Blair, D. G., & Athanasiou, M. (2000) · Oncogene · doi:10.1038/sj.onc.1204046 · Cited by 45
“A search for a unique viral integration site to explain the clonal nature of the disease led to the identi®cation of a common integration locus in erythroid tumors (Moreau-Gachelin et al., 1988; Spiro et al., 1988).”
BackgroundInfluentialPartington, G. A., Fuller, K., Chambers, T. J., & Pondel, M. D. (2003) · Bone · doi:10.1016/j.bone.2003.11.010 · Cited by 40
Gene therapy for Parkinson's disease
Horellou, P., & Mallet, J. J. (1997) · Molecular Neurobiology · doi:10.1007/bf02740636 · Cited by 35
Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells
Delestré, L., Cui, H., Esposito, M., Quiveron, C., Mylonas, E., Penard-Lacronique, V., Bischof, O., & Guillouf, C. (2017) · Haematologica · doi:10.3324/haematol.2016.157636 · Cited by 32
Teal, H. E., Ni, S., Xu, J., Finkelstein, L. D., Cheng, A. M., Paulson, R. F., Feng, G.-S., & Correll, P. H. (2005) · Oncogene · doi:10.1038/sj.onc.1209288 · Cited by 31
Ets-1 Regulates fli-1 Expression in Endothelial Cells
Lelièvre, E., Lionneton, F., Mattot, V., Spruyt, N., & Soncin, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201628200 · Cited by 35
GSKB: A gene set database for pathway analysis in mousePreprint
Lai, L., Hennessey, J., Bares, V., Son, E., Ban, Y. J., Wang, W., Qi, J., Jiang, G., Liberzon, A., & Ge, X. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/082511 · Cited by 34
“The target genes of SPI1 (Spleen focus forming virus proviral integration oncogene, also listed as SFPI1) are highly expressed in spleen and bone marrow, in agreement with the fact that SPI1 is an ETS-domain transcription factor involved in myeloid and B-lymphoid cell development [32].”
BackgroundRadiation-induced myeloid leukemia in murine models
Rivina, L., Davoren, M. J., & Schiestl, R. H. (2014) · Human Genomics · doi:10.1186/1479-7364-8-13 · Cited by 35
“It is essential for proper terminal myeloid cell differentiation (macrophage and neutrophil), as well as stem cell maintenance [87-91].”
BackgroundXu, L., Sokalski, K. M., Hotke, K., Christie, D. A., Zarnett, O. J., Piskorz, J., Thillainadesan, G., Torchia, J., & DeKoter, R. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201267 · Cited by 32
“1 was discovered as a gene upregulated in murine erythroleukemia as a consequence of proviral insertion by the murine SFFV retrovirus (42).”
BackgroundLocalization of the human oncogene SPI1 on chromosome 11, region p11.22
Cong, N. V., Ray-Gallet, D., Gross, M., de Tand, M.-F., Frézal, J., & Moreau-Gachelin, F. (1990) · Human Genetics · doi:10.1007/bf00210807 · Cited by 30
“The previously described probe (Moreau-Gachelin et al. 1988) in the main SFFV provirus insertion site is localized near the Spil gene.”
BackgroundResultSelf-citationBurda, P., Curik, N., Kokavec, J., Basova, P., Mikulenkova, D., Skoultchi, A. I., Zavadil, J., & Stopka, T. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0031 · Cited by 28
Skoda, R. C., Tsai, S., Orkin, S. H., & Leder, P. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1603 · Cited by 31
An erythroid-to-myeloid cell fate conversion is elicited by LSD1 inactivation
Yu, L., Myers, G., Ku, C.-J., Schneider, E., Wang, Y., Singh, S. A., Jearawiriyapaisarn, N., White, A. D., Moriguchi, T., Khoriaty, R. N., et al. (2021) · Blood · doi:10.1182/blood.2021011682 · Cited by 33
PU.1 Binds to a Distal Regulatory Element That Is Necessary for B Cell-Specific Expression of CIITA
Yoon, H., & Boss, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000079 · Cited by 29
Coutte, L., Monté, D., Imai, K., Pouilly, L., Dewitte, F., Vidaud, M., Adamski, J., Baert, J., & de Launoit, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1203020 · Cited by 29
“Some of these genes become oncogenic by retroviral insertional mutagenesis (Moreau-Gachelin et al., 1988; Ben David et al., 1991) or by chromosomal translocations in myeloid leukemia (Shimizu et al., 1993; Golub et al., 1994) and Ewing's sarcomas (Delattre et al., 1992; Zucman et al., 1993).”
BackgroundDittmer, U., Brooks, D. M., & Hasenkrug, K. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3753-3757.1999 · Cited by 29
“In susceptible adult animals, FV induces rapid polyclonal erythroblast proliferation (19, 23) followed within weeks by erythroleukemia (24, 25, 32).”
BackgroundPU.1 supports proliferation of immature erythroid progenitors
Fisher, R. C., Slayton, W. B., Chien, C. D., Guthrie, S. M., Bray, C. L., & Scott, E. W. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00178-4 · Cited by 30
Transcriptional activity and constitutive nuclear localization of the ETS protein Elf‐1
Bredemeier-Ernst, I., Nordheim, A., & Janknecht, R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00387-6 · Cited by 30
Spi-1/PU.1 activates transcription through clustered DNA occupancy in erythroleukemia
Ridinger-Saison, M., Boeva, V., Rimmelé, P., Kulakovskiy, I., Gallais, I., Levavasseur, B., Paccard, C., Legoix-Né, P., Morlé, F., Nicolas, A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks659 · Cited by 28
“Moreover, in the erythroleukemic context, Spi-1 is highly expressed in each cell (1).”
BackgroundSelf-citationZhao, S., Tan, Y., Qin, J., Xu, H., Liu, L., Wan, H., Zhang, C., Fan, W., & Qu, S. (2022) · Toxicology · doi:10.1016/j.tox.2022.153252 · Cited by 29
Ski Negatively Regulates Erythroid Differentiation through Its Interaction with GATA1
Ueki, N., Zhang, L., & Hayman, M. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.23.10118-10125.2004 · Cited by 33
“1, a myeloid- and B-cell-specific ETS transcription factor, has been shown to inhibit GATA1 function and is implicated in Friend virus-induced murine erythroleukemia (26).”
BackgroundStrestik, B. D., Olbrich, A. R. M., Hasenkrug, K. J., & Dittmer, U. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-6-1349 · Cited by 28
“In susceptible strains, disease progresses to lethal erythroleukaemia ( Moreau-Gachelin et al., 1988; Munroe et al., 1990; Wendling & Tambourin, 1978).”
BackgroundThe transcription factor PU.1 does not regulate lineage commitment but has lineage-specific effects
McKercher, S. R., Henkel, G. W., & Maki, R. A. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.727 · Cited by 28
“1 is also known as the oncogene spi-1 because it was independently discovered as the gene induced by insertion of the Friend murine leukemia virus [2].”
BackgroundCloning and expression of the murine Elf-1 cDNA
Davis, J. N., & Roussel, M. F. (1996) · Gene · doi:10.1016/0378-1119(96)00013-3 · Cited by 30
Clinical relevance of Elf-1 overexpression in endometrial carcinoma
Takai, N., Miyazaki, T., Nishida, M., Shang, S., Nasu, K., & Miyakawa, I. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00131-8 · Cited by 27
Li, X., Vradii, D., Gutiérrez, S., Lian, J. B., van Wijnen, A. J., Stein, J. L., Stein, G. S., & Javed, A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20548 · Cited by 30
“1 is an Ets-family transcription factor that also controls many genes critical for development of the hematopoietic system [Moreau-Gachelin et al., 1988; Scott et al., 1994; McKercher et al., 1996; Hromas et al., 1997].”
BackgroundFriend Virus Utilizes the BMP4-Dependent Stress Erythropoiesis Pathway To Induce Erythroleukemia
Subramanian, A., Hegde, S., Porayette, P., Yon, M., Hankey, P. A., & Paulson, R. F. (2007) · Journal of Virology · doi:10.1128/jvi.02487-06 · Cited by 27
“1 (33), which leads to the emergence of a leukemic clone and eventually erythroleukemia.”
BackgroundHashimoto, S.-I., Nishizumi, H., Hayashi, R., Tsuboi, A., Nagawa, F., Takemori, T., & Sakano, H. (1999) · International Immunology · doi:10.1093/intimm/11.9.1423 · Cited by 27
Dittmer, U., Race, B., & Hasenkrug, K. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8435-8440.1999 · Cited by 27
“Proliferation of these precursors expands the population of target cells for retroviral infection, and lethal erythroleukemia ensues within several weeks of initial infection ( 29 , 31, 38).”
BackgroundLacombe, C., Chrétien, S., Lemarchandel, V., Mayeux, P., Roméo, P., Gisselbrecht, S., & CARTRON, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89595-7 · Cited by 27
Delva, L., Gallais, I., Guillouf, C., Denis, N., Orvain, C., & Moreau-Gachelin, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207578 · Cited by 26
“Spi-1 insertional mutagenesis leads to the transcriptional activation of spi-1 in the proerythroblast (Moreau-Gachelin et al., 1988).”
BackgroundSelf-citationSood, R. B., & Liu, P. (2012) · Advances in Hematology · doi:10.1155/2012/830703 · Cited by 28
“1), an oncogene originally identified as the site of genomic rearrangements by spleen focus-forming proviral insertion in erythroblastic tumors [103].”
BackgroundKleinbaum, L. A., Duggan, C. R., Ferreira, E., Coffey, G., Butticè, G., & Burton, F. H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1493 · Cited by 28
10 Erythroleukaemia induction by the Friend spleen focus-forming virus
Ruscetti, S. K. (1995) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80239-2 · Cited by 34
Dittmer, U., Sutter, K., Kassiotis, G., Zelinskyy, G., Bánki, Z., Stoiber, H., Santiago, M. L., & Hasenkrug, K. J. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz012 · Cited by 27
“In susceptible mice that fail to mount rapid T helper cell, CD8+ T cell and B cell responses, the SFFV genome eventually integrates into and activates the Spi-1 transcriptional factor gene (Moreau-Gachelin, Tavitian and Tambourin 1988; Paul et al.”
BackgroundCofré, J., Menezes, J. R. L., Pizzatti, L., & Abdelhay, E. S. F. W. (2012) · Cancer Cell International · doi:10.1186/1475-2867-12-28 · Cited by 25
“1 is a hematopoietic lineage- specific ETS (Erythroblast Transformation Specific) family member [57] that is absolutely required for normal hematopoiesis [58].”
BackgroundWong, K. S., Li, Y., Howard, J., & Ben‐David, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202938 · Cited by 26
“Analysis of other oncogenes documented in related erythroleukemias and myeloid leukemias, including Sfpi-1, Evi-1, c-Myc, and Pim-1, shows them not to be involved (Bartholomew and Ihle, 1991; Bordereaux et al., 1987; Dreyfus et al., 1990; Moreau-Gachelin et al., 1988).”
BackgroundDominant-interfering C/EBPα stimulates primitive erythropoiesis in zebrafish
Liu, T. X., Rhodes, J., Deng, M., Hsu, K., Radomska, H. S., Kanki, J. P., Tenen, D. G., & Look, A. T. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.10.008 · Cited by 25
Levy, L., & Lobelle‐Rich, P. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2885-2892.1992 · Cited by 24
“fim-3, evi-1, evi-2, spi-1, and dsi-J (5, 7, 10, 24, 26, 34, 37, 38, 43, 46, 47) occurs in a significant proportion of lymphomas and leukemias induced in rodents by infection with MuLV.”
BackgroundBurda, P., Vargova, J., Čuřík, N., Šálek, C., Papadopoulos, G. L., Strouboulis, J., & Stopka, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152234 · Cited by 27
“AML-EL CD34 + cells were magnetically sorted with 95% purity.”
InfluentialOncogene Activation in Myeloid Leukemias by Graffi Murine Leukemia Virus Proviral Integration
Denicourt, C., Edouard, E., & Rassart, É. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4439-4442.1999 · Cited by 27
“1 and Fli-1 are both members of the ets family of transcription factors and were identified as a consequence of their activation in Friend virus-induced erythroleukemia (6, 7, 26, 32).”
BackgroundChen, J., Kremer, C. S., & Bender, T. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205003 · Cited by 23
“Most MEL cell lines established from this second step contain SFFV proviral integration at the Spi-1 locus, resulting in transcriptional activation of the ETS family transcription factor PU.1/Spi1-1 (Moreau-Gachelin et al., 1988, 1989).”
BackgroundHuman N‐Acetylglucosaminyltransferase III Gene is Transcribed from Multiple Promoters
Koyama, N., Miyoshi, E., Ihara, Y., Kang, R., Nishikawa, A., & Taniguchi, N. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0853w.x · Cited by 24
Molecular Analysis of Evi1, a Zinc Finger Oncogene Involved in Myeloid Leukemia
Lopingco, M. C., & Perkins, A. S. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_21 · Cited by 26
Oval, J., & Taetle, R. (1990) · Blood Reviews · doi:10.1016/0268-960x(90)90007-f · Cited by 23
Humoral immunity in the Friend retrovirus infection model
Halemano, K., Harper, M. S., Guo, K., Li, S. X., Heilman, K. J., Barrett, B. S., & Santiago, M. L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8370-y · Cited by 22
“Subsequent erythroleukemia is linked to proviral integration events into the host genome near proto-oncogenes and tumor suppressor genes [11, 12].”
Fukushima, T., Miyazaki, Y., Tsushima, H., Tsutsumi, C., Taguchi, J., Yoshida, S., Kuriyama, K., Scadden, D. T., Nimer, S. D., & Tomonaga, M. (2003) · Leukemia Research · doi:10.1016/s0145-2126(02)00214-x · Cited by 23
Papetti, M., & Skoultchi, A. I. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0145 · Cited by 26
“1 synthesis, occur in at least 95% of erythroleukemias in Friend virus– infected mice (12).”
BackgroundHensold, J. O., Stratton, C. A., Barth, D., & Galson, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3385 · Cited by 21
Prostacyclin receptors: Transcriptional regulation and novel signalling mechanisms
Reid, H. M., & Kinsella, B. T. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.008 · Cited by 21
Li, Y., Higgins, R. R., Pak, B. J., Shivdasani, R. A., Ney, P. A., Archer, M. C., & Ben‐David, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.73-80.2001 · Cited by 21
Bochert, M. A., Kleinbaum, L. A., Sun, L.-Y., & Burton, F. H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8560 · Cited by 21
PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.
Ueno, S., Tatetsu, H., Hata, H., Iino, T., Niiro, H., Akashi, K., Tenen, D. G., Mitsuya, H., & Okuno, Y. (2009) · Oncogene · doi:10.1038/onc.2009.263 · Cited by 20
“In Friend leukemia, FEEV is integrated into the 14-kb 50-upstream region of the PU.1 gene locus and results in failure of PU.1 downregulation in erythroblasts, thereby leading to erythroleukemia in mice (Moreau-Gachelin et al., 1988).”
BackgroundThillo, Q. V., Bie, J. D., Seneviratne, J. A., Demeyer, S., Omari, S. A., Balachandran, A., Zhai, V., Tam, W. L., Sweron, B., Geerdens, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24442-9 · Cited by 21
Brown, N., Finnon, R., Manning, G., Bouffler, S. D., & Badie, C. (2015) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2015.07.012 · Cited by 26
Delgado, M. D., Gutiérrez, P., Richard, C., Cuadrado, M. A., Moreau-Gachelin, F., & León, J. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9587 · Cited by 25
Self-citationInsertional mutations in mammals and mammalian cells
Favor, J., & Morawetz, C. (1992) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(92)90024-v · Cited by 22
The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1
Barbeau, B., Barat, C., Bergeron, D., & Rassart, É. (1999) · Oncogene · doi:10.1038/sj.onc.1202913 · Cited by 23
“Factors B and B' both bind to the two EBS-containing regions, the weakest a nity interaction being represented by an incomplete arrow induced erythroleukemias (Moreau-Gachelin et al., 1988; Goebl et al., 1990).”
BackgroundDittmer, U., & Hasenkrug, K. J. (2000) · Virology · doi:10.1006/viro.2000.0356 · Cited by 20
Pharmacogenetics of Alkylator-Associated Acute Myeloid Leukemia
Knoche, E., McLeod, H. L., & Graubert, T. A. (2006) · Pharmacogenomics · doi:10.2217/14622416.7.5.719 · Cited by 19
PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells
Fernández-Nestosa, M. J., Hernández, P., Schvartzman, J. B., & Krimer, D. B. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.05.008 · Cited by 22
Hegde, S., Hankey, P. A., & Paulson, R. F. (2011) · Stem Cells · doi:10.1002/stem.781 · Cited by 19
The Ets family of transcription factors
Wasylyk, B., Hahn, S. L., & Giovane, A. (1994) · Springer eBooks · doi:10.1007/978-3-642-78757-7_2 · Cited by 260
Kawaguchi, Y., Hara, M., Kamatani, N., & Wright, T. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10730 · Cited by 21
Spiro, C., Gliniak, B., & Kabat, D. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4129-4135.1988 · Cited by 19
“This inherent difficulty has been exacerbated because SFFV has been almost exclusively analyzed in the presence of helper MuLV, which creates opportunities for multiple infections of tumor cells (21-23) and for continual infection of previously uninfected erythroblasts in vivo.”
BackgroundInfluentialHino, M., Tojo, A., Misawa, Y., Morii, H., Takaku, F., & Shibuya, M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5527-5533.1991 · Cited by 19
“This step involves disruption of the p53 gene (6, 34, 38) and/or activation of the Spi-J gene (32), in which there is evidence of the insertion of the F-SFFVp provirus.”
BackgroundDNA methylation-mediated silencing of PU.1 in leukemia cells resistant to cell differentiation
Fernández-Nestosa, M. J., Monturus, E., Sánchez, Z., Torres, F. S., Fernández, A. F., Fraga, M. F., Hernández, P., Schvartzman, J. B., & Krimer, D. B. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-392 · Cited by 20
“1 (also called Sfpi-1 or Spi-1) gene (Moreau-Gachelin et al. 1988; Paul et al. 1989).”
Cmarik, J. L., & Ruscetti, S. K. (2010) · Viruses · doi:10.3390/v2102235 · Cited by 26
“When malignant cells from SFFV-infected mice are examined for common sites of integration, almost all of them contain SFFV integrated at the Sfpi1 locus [77–79].”
BackgroundAudit, M., Déjardin, J., Hohl, B., Sidobre, C., Hope, T. J., Mougel, M., & Sitbon, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10472-10479.1999 · Cited by 18
“Although insertional mutagenesis has generally been described for replication-competent MuLVs lacking oncogenes, this mechanism has also been shown to participate in transformation following infection with replication-defective MuLV (34, 44).”
BackgroundProvirus tagging as an instrument to identify oncogenes and to establish synergism between oncogenes
Berns, A. J. M. (1988) · Archives of Virology · doi:10.1007/bf01315558 · Cited by 18
Mouse Models of Radiation-Induced Cancers
Rivina, L., & Schiestl, R. H. (2013) · Advances in genetics · doi:10.1016/b978-0-12-407703-4.00003-7 · Cited by 18
Wang, M., Liu, Z., Liu, C., Wu, T. H., Cai, F., Wang, Q., Su, X., & Shi, Y. P. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1632-x · Cited by 18
“1, a member of the E-twenty-six (ETS) family, is a transcription factor that is essential for the development of hematopoietic stem cells and regulation of the immune response [8, 9].”
BackgroundBonnet, D. A. (2003) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.10018 · Cited by 17
Genetic analysis of transcription factors implicated in B lymphocyte development
Singh, H. (1994) · Immunologic Research · doi:10.1007/bf02935619 · Cited by 18
“The Spi-1 locus is the site of integration of the spleen focus-forming proviurs in 95 % of murine erythroleukemias induced by Friend virus complexes [ 52 ].”
BackgroundHematopoietic transcription regulators and the origins of leukemia
Hromas, R., Zon, L. I., & Friedman, A. D. (1992) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(92)90088-8 · Cited by 18
PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1
Ziliotto, R. G., Gruca, M. R., Podder, S., Noel, G., Ogle, C. K., Hess, D. A., & DeKoter, R. P. (2013) · Experimental Hematology · doi:10.1016/j.exphem.2013.11.011 · Cited by 16
“011 proviral insertion of the spleen focus-forming virus (SFFV) inmurine erythroleukemia [9].”
Turner, E. C., & Kinsella, B. T. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.12.030 · Cited by 17
Jelacic, T. M., Thompson, D. M., Hanson, C. A., Cmarik, J. L., Nishigaki, K., & Ruscetti, S. K. (2007) · Journal of Virology · doi:10.1128/jvi.01349-07 · Cited by 16
“1) due to a proviral insertion event (12, 13, 24, 25).”
BackgroundHemopoietic growth factor receptor abnormalities in leukemia
Alexander, W. S., & Nicola, N. A. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00110-6 · Cited by 16
Nishigaki, K., Hanson, C. A., Ohashi, T., Spadaccini, A., & Ruscetti, S. (2006) · Journal of Virology · doi:10.1128/jvi.02651-05 · Cited by 19
“The second stage of the disease consists of the outgrowth of Friend SFFV-infected erythroid cells that have become transformed due to integration of the virus into the Sfpi-1 locus (29, 39, 40).”
BackgroundTarr, K. L., Watowich, S. S., & Longmore, G. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9099 · Cited by 16
Nishigaki, K., Hanson, C. A., Thompson, D. M., Yugawa, T., & Ruscetti, S. K. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12752-12762.2005 · Cited by 17
“The second stage of the disease consists of the outgrowth of Friend SFFVinfected erythroid cells that have become transformed due to integration of the virus into the Sfpi-1 locus ( 31 , 43, 44).”
BackgroundShen, H., Suzuki, T., Munroe, D. J., Stewart, C., Rasmussen, L. A., Gilbert, D. J., Jenkins, N. A., & Copeland, N. G. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1584-1588.2003 · Cited by 15
“Sfpi1 is a gene that was originally identified at a common site of retroviral integration in murine erythroleukemias induced by the acute leukemogenic retrovirus spleen focus-forming virus (13, 15).”
BackgroundHemopexin in the human retina: Protection of the retina against heme-mediated toxicity
Hunt, R. C., Hunt, D. M., Gaur, N., & Smith, A. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199607)168:1<71::aid-jcp9>3.0.co;2-5 · Cited by 68
Hensold, J., Stratton, C. A., & Barth, D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2869 · Cited by 16
Insertional Mutagenesis: Neoplasia Arising from Retroviral Integration
Bell, J. C., Sonnenberg, N., & Gray, D. A. (1991) · Cancer Investigation · doi:10.3109/07357909109021327 · Cited by 15
Subramanian, A., Teal, H. E., Correll, P. H., & Paulson, R. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14586-14594.2005 · Cited by 14
“The later stage is characterized by the acquisition of new mutations, specifically, the mutation of the p53 gene and proviral insertional activation of Spi1, which leads to the emergence of a leukemic clone (20, 21).”
BackgroundThéoleyre, O., Deguillien, M., Morinière, M., Starck, J., Moreau-Gachelin, F., Morlé, F., & Baklouti, F. (2003) · Oncogene · doi:10.1038/sj.onc.1207206 · Cited by 15
“Most of the SFFV-induced erythroleukemia cells (SFFV cells) are associated with activation of the spi-1/pu.1 gene through proviral insertion, leading to overexpression of the ETS family transcription factor Spi-1/PU.1 (Moreau-Gachelin et al., 1988).”
BackgroundSelf-citationAno, S., Pereira, R., Pironin, M., Lesault, I., Milley, C., Lebigot, I., Quang, C. T., & Ghysdael, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m303816200 · Cited by 16
Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia
Prasher, J. M., Elenitoba‐Johnson, K. S. J., & Kelley, L. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204395 · Cited by 14
“In the vast majority of cases (60% (Koury et al., 1997) 72% (Paul et al., 1989) and 95% (Moreau-Gachelin et al., 1988, 1989, 1990)), PU.1 overexpression occurs as a result of SFFV integration upstream of the PU.1 locus resulting in gene rearrangement, which can be detected by Southern blot analysis.”
BackgroundJoosten, M., Valk, P. J. M., Vankan, Y., Both, N. J. D., Löwenberg, B., & Delwel, R. (2000) · Virology · doi:10.1006/viro.2000.0183 · Cited by 14
Metadata
- Authors
- Moreau-Gachelin, F., Tavitian, A., & Tambourin, P.
- Affiliations
- Inserm (FR)
- Venue
- Nature
- Published
- 1988-01
- Volume
- 331
- Issue
- 6153
- Pages
- 277-280
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1975584136
- Cited by
- 447
- References
- 26
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 10 · 2012: 11
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Keywords
- SPI-1, spleen focus-forming virus, retroviral insertional mutagenesis, retroviral integration, chromosomal rearrangements, avian leukosis virus, murine leukemia virus, retroviral oncogenesis
- MeSH terms
- Animals, Cell Transformation, Viral, DNA, Neoplasm, DNA, Viral, Leukemia, Erythroblastic, Acute, Friend murine leukemia virus, Leukemia, Experimental, Mice, Inbred CBA, Mice, Inbred DBA, Leukemia Virus, Murine, Oncogenes, Proviruses, RNA, Messenger, RNA, Neoplasm, Spleen Focus-Forming Viruses, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.